FBXO38 deficiency promotes lysosome-dependent STING degradation and inhibits cGAS–STING pathway activation

IF 4.8 2区 医学 Q1 Biochemistry, Genetics and Molecular Biology
Yijia Wu , Yao Lin , Feiyang Shen , Rui Huang , Zhe Zhang , Min Zhou , Yan Fang , Jianfeng Shen , Xianqun Fan
{"title":"FBXO38 deficiency promotes lysosome-dependent STING degradation and inhibits cGAS–STING pathway activation","authors":"Yijia Wu ,&nbsp;Yao Lin ,&nbsp;Feiyang Shen ,&nbsp;Rui Huang ,&nbsp;Zhe Zhang ,&nbsp;Min Zhou ,&nbsp;Yan Fang ,&nbsp;Jianfeng Shen ,&nbsp;Xianqun Fan","doi":"10.1016/j.neo.2024.100973","DOIUrl":null,"url":null,"abstract":"<div><p>F-box only protein 38 (FBXO38) is a member of the F-box family that mediates the ubiquitination and proteasome degradation of programmed death 1 (PD-1), and thus has important effects on T cell-related immunity. While its powerful role in adaptive immunity has attracted much attention, its regulatory roles in innate immune pathways remain unknown. The cyclic GMP–AMP synthase–stimulator of interferon genes (cGAS–STING) pathway is an important innate immune pathway that regulates type I interferons. STING protein is the core component of this pathway. In this study, we identified that FBXO38 deficiency enhanced tumor proliferation and reduced tumor CD8<sup>+</sup> T cells infiltration. Loss of FBXO38 resulted in reduced STING protein levels <em>in vitro</em> and <em>in vivo</em>, further leading to preventing cGAS–STING pathway activation, and decreased downstream product IFNA1 and CCL5. The mechanism of reduced STING protein was associated with lysosome-mediated degradation rather than proteasomal function. Our results demonstrate a critical role for FBXO38 in the cGAS–STING pathway.</p></div>","PeriodicalId":18917,"journal":{"name":"Neoplasia","volume":null,"pages":null},"PeriodicalIF":4.8000,"publicationDate":"2024-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1476558624000101/pdfft?md5=3e3dfa7185c2f241393c6b7aee4f9571&pid=1-s2.0-S1476558624000101-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neoplasia","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1476558624000101","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 0

Abstract

F-box only protein 38 (FBXO38) is a member of the F-box family that mediates the ubiquitination and proteasome degradation of programmed death 1 (PD-1), and thus has important effects on T cell-related immunity. While its powerful role in adaptive immunity has attracted much attention, its regulatory roles in innate immune pathways remain unknown. The cyclic GMP–AMP synthase–stimulator of interferon genes (cGAS–STING) pathway is an important innate immune pathway that regulates type I interferons. STING protein is the core component of this pathway. In this study, we identified that FBXO38 deficiency enhanced tumor proliferation and reduced tumor CD8+ T cells infiltration. Loss of FBXO38 resulted in reduced STING protein levels in vitro and in vivo, further leading to preventing cGAS–STING pathway activation, and decreased downstream product IFNA1 and CCL5. The mechanism of reduced STING protein was associated with lysosome-mediated degradation rather than proteasomal function. Our results demonstrate a critical role for FBXO38 in the cGAS–STING pathway.

缺乏 FBXO38 会促进溶酶体依赖性 STING 降解,并抑制 cGAS-STING 通路的激活
F-box唯一蛋白38(FBXO38)是F-box家族的成员,它能介导程序性死亡1(PD-1)的泛素化和蛋白酶体降解,从而对T细胞相关免疫产生重要影响。尽管它在适应性免疫中的强大作用备受关注,但它在先天性免疫途径中的调控作用仍不为人知。环GMP-AMP合成酶-干扰素基因刺激器(cGAS-STING)通路是调节I型干扰素的重要先天性免疫通路。STING 蛋白是该通路的核心成分。在这项研究中,我们发现 FBXO38 缺乏会增强肿瘤增殖并减少肿瘤 CD8+ T 细胞浸润。缺失 FBXO38 会导致体外和体内 STING 蛋白水平降低,进一步导致 cGAS-STING 通路活化受阻,下游产物 IFNA1 和 CCL5 减少。STING 蛋白减少的机制与溶酶体介导的降解而非蛋白酶体功能有关。我们的研究结果证明了 FBXO38 在 cGAS-STING 通路中的关键作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Neoplasia
Neoplasia 医学-肿瘤学
CiteScore
9.20
自引率
2.10%
发文量
82
审稿时长
26 days
期刊介绍: Neoplasia publishes the results of novel investigations in all areas of oncology research. The title Neoplasia was chosen to convey the journal’s breadth, which encompasses the traditional disciplines of cancer research as well as emerging fields and interdisciplinary investigations. Neoplasia is interested in studies describing new molecular and genetic findings relating to the neoplastic phenotype and in laboratory and clinical studies demonstrating creative applications of advances in the basic sciences to risk assessment, prognostic indications, detection, diagnosis, and treatment. In addition to regular Research Reports, Neoplasia also publishes Reviews and Meeting Reports. Neoplasia is committed to ensuring a thorough, fair, and rapid review and publication schedule to further its mission of serving both the scientific and clinical communities by disseminating important data and ideas in cancer research.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信